Around 27% of essential drugs on the FDA list are categorised as 'at risk' due to uncertain supply chains. CyanoCapture is an advanced Synthetic Biology company that is leveraging the world's fastest carbon-negative cell to synthesise drug precursor molecules at lower cost and address this problem. Winner - Elon Musk XPRIZE 2021 Winner - Shell New Energy Challenge 2022 Winner - Horizon Europe 2024 Winner - L'Oreal GSI x Hello Tomorrow 2024 Enquiries: Partnerships@cyanocapture.com Licensing@cyanocapture.com
| Website | http://www.cyanocapture.com |
| Employees | 12 (6 on RocketReach) |
| Founded | 2021 |
| Address | Roosevelt Drive, Oxford, England OX3 7XB, GB |
| Industry | Biotechnology |
| Keywords | Carbon Capture, Carbon Removal, Direct Air Capture, Carbon Sequestration, Negative Emissions, Climate Tech, Biotechnology, Industrial Decarbonization, Emission Reduction, Sustainable Technology, Clean Technology, Photosynthesis, Green Technology, Genetic Engineering, Algae, Environmental Technology, Sustainable Solutions, Climate Change, Renewable Energy |
| Competitors | Climeworks, XPRIZE, LanzaTech, Carbon Engineering Ltd., CarbonCure Technologies, Global CCS Institute, Carbon Clean, Aircapture, C-Capture Ltd., Leeds +22 more (view full list) |
Looking for a particular CyanoCapture employee's phone or email?
CyanoCapture Questions
David K. is the CEO of CyanoCapture.
6 people are employed at CyanoCapture.
CyanoCapture is based in Oxford, England.
Top CyanoCapture Employees
-
David K.
CEO at CyanoCapture
San Francisco, CA, US
Related Companies
